The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

North America held the largest biohacking market share and was the fastest-growing region in 2022.

The global biohacking market is expected to grow from $23.34 billion in 2022 to $28.87 billion in 2023 at a compound annual growth rate (CAGR) of 23.7%. The biohacking market size is expected to grow to $65.95 billion in 2027 at a CAGR of 22.9%.

Major Driver In The Biohacking Market ­– Rise In The Prevalence Of Chronic Diseases
According to the World Health Organisation, a US-based specialised organisation responsible for international public health, chronic illness incidence is expected to increase by 57% by 2020. In addition, 19.3 million new cancer cases were documented in 2020, with about 10.0 million cancer deaths. As a result, the increased prevalence of chronic diseases is propelling the biohacking market forward.

View More On The Biohacking Market Report 2023 – https://www.thebusinessresearchcompany.com/report/biohacking-global-market-report

Key Biohacking Market Segments
1) By Product: Wearables, Implants (Chips), Gene Modification Kits, Smart Drugs, Supplements, Mobile Apps, Other Products
2) By Component: Solution, Services
3) By Application: Synthetic Biology, Genetic Engineering, Forensic Science, Diagnosis and Treatment, Drug Testing
4) By End-User: Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, Forensic Laboratories, Research and Academic Institutes, Other End Users

Recent Biohacking Market Trend – Product Advancement
Major biohacking companies are focusing on new product advances in order to strengthen their market position. For example, Velovita, a biohacking solutions provider based in the United States, developed Zlem, a dietary supplement bio-hacking formula for quality sleep and weight control, in January 2022. Zlem is a powerful supplement that contains over 20 components that can help people sleep better and burn fat that has collected in the body while sleeping. This medication also aids in the removal of pollutants from the body and provides consumers with a balanced, healthy state of mind every morning.

Biohacking Market Prominent Players
Major players in the biohacking market are Thync Global Inc., Fitbit Inc., OsteoStrong, HVMN Inc., Thriveport LLC, Apple Inc., Kaatsu Global, TrackMyStack, Interaxon Inc., SynBioBeta LLC, Elysium Health, InteraXon Inc., Behavioral Tech, Synbiota, and Primal Life Sciences.

Request A Sample Of The Global Biohacking Market Report 2023:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7316&type=smp

The Biohacking Global Market Report 2023  provides a comprehensive overview on the biohacking market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the biohacking market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Biohacking, also known as human augmentation or human enhancement, is a sort of do-it-yourself biology that seeks to improve ability, fitness, and well-being by deliberate interventions.

View More Related Reports –
Bioinformatics Global Market Report 2023
Biostimulants Global Market Report 2023
Biosimilars Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model